sever
acut
respiratori
diseas
caus
respiratori
viru
infect
individu
age
year
older
highrisk
adult
chronic
cardiopulmonari
disord
associ
increas
hospit
mortal
rate
epidemiolog
studi
identifi
influenza
viru
respiratori
syncyti
viru
frequent
caus
virusinduc
respiratori
diseas
elderli
highrisk
adult
studi
human
anim
model
establish
fundament
defect
cellmedi
humor
immun
respons
age
individu
howev
well
understood
age
specif
alter
immun
respons
respiratori
pathogen
review
focu
discuss
major
caus
agent
sever
respiratori
viru
infect
elderli
highrisk
adult
ageassoci
defect
immun
respons
probabl
contribut
increas
diseas
sever
observ
popul
respiratori
viru
infect
major
caus
morbid
mortal
elderli
highrisk
adult
death
associ
respiratori
viru
infect
increas
last
sever
decad
usa
part
reflect
increas
number
elderli
person
number
individu
age
year
doubl
proport
adult
age
year
continu
increas
owe
increas
frailti
senesc
immun
system
highrisk
factor
chronic
cardiopulmonari
disord
adult
age
year
much
like
succumb
respiratori
viru
infect
influenza
viru
respiratori
syncyti
viru
rsv
two
lead
caus
virusinduc
sever
respiratori
diseas
major
caus
viru
correspond
induc
sever
respiratori
diseas
includ
human
metapneumoviru
hmpv
human
parainfluenza
viru
hpiv
rhinoviru
coronaviru
understand
effect
immun
senesc
contribut
risk
factor
increas
diseas
sever
elderli
paramount
vaccin
develop
design
immunotherapeut
deterior
adapt
immun
respons
well
document
elderli
individu
ageassoci
defect
occur
hematopoiesi
lymphocyt
mainten
peripher
lymphocyt
pool
virusspecif
respons
cellmedi
humor
immun
necessari
viru
clearanc
protect
immun
reinfect
primari
viru
infect
cellmedi
immun
primarili
respons
viru
clearanc
well
establish
cellmedi
immun
declin
immun
system
age
thymu
tcell
progenitor
develop
matur
cell
whereupon
migrat
peripheri
naiv
repertoir
cell
establish
earli
life
thymic
involut
begin
within
year
birth
fifth
decad
life
thymu
replac
adipos
tissu
although
low
level
thymopoiesi
continu
late
life
interestingli
thymu
capabl
regener
involut
caus
cancer
chemotherapi
infect
howev
involut
caus
age
appear
irrevers
suggest
senescenceacquir
chang
thymic
environ
thymic
output
decreas
age
overal
divers
within
repertoir
naiv
cell
reduc
exist
peripher
cell
age
accru
intrins
defect
alter
tcell
respons
pathogen
human
tcell
receptor
divers
drastic
chang
seventh
decad
life
concomit
signific
increas
homeostat
prolifer
peripher
cell
homeostat
prolifer
increas
perhap
compens
decreas
thymopoiesi
result
accumul
pathogen
exposur
time
skew
peripher
tcell
pool
naiv
cell
overrepresent
cell
memori
phenotyp
phenomenon
may
part
longer
histori
antigen
exposur
fraction
tcell
recent
thymic
emigr
rte
age
mice
alreadi
memori
phenotyp
hi
lo
suggest
defect
alreadi
present
cell
newli
gener
age
host
skew
tcell
repertoir
accumul
respons
new
pathogen
may
consist
crossreact
memori
cell
number
naiv
cell
requir
mount
effect
respons
may
fall
critic
threshold
upon
infect
pathogen
naiv
cell
activ
antigenpres
cell
undergo
vigor
clonal
expans
develop
effector
function
combat
infect
age
naiv
cell
exhibit
diminish
format
immunolog
synaps
antigenpres
cell
display
cognat
peptid
poor
local
signal
molecul
downstream
tcell
receptor
addit
activ
age
cell
prolifer
poorli
exhibit
decreas
traffick
infect
tissu
alter
cytokin
profil
less
effici
clear
pathogen
interestingli
defect
cell
appear
part
depend
postthym
age
naiv
cell
age
anim
memori
cell
gener
young
naiv
cell
remain
function
well
old
age
importantli
defect
observ
naiv
cell
obtain
age
mice
attribut
postthym
age
cell
tcell
rte
age
mice
exhibit
decreas
ca
flux
prolifer
product
compar
rte
young
mice
follow
antigen
stimul
activ
via
tcell
receptor
bone
marrow
transfer
experi
demonstr
defect
rte
age
mice
appear
aris
ageassoci
chang
tcell
progenitor
thymic
environ
final
cell
provid
help
b
cell
cytotox
cell
evid
age
naiv
cell
provid
poor
help
bcell
respons
possibl
cytolyt
cell
multipl
line
evid
suggest
agedepend
chang
overal
pool
cell
may
lessen
efficaci
respons
first
naiv
tcell
repertoir
shrink
age
reduc
number
naiv
precursor
capabl
respond
particular
antigen
critic
threshold
contract
naiv
tcell
repertoir
greatli
alter
magnitud
respons
second
addit
increas
ratio
memori
naiv
cell
age
individu
memori
cell
form
clonal
expans
domin
tcell
pool
possibl
compet
naiv
cell
respons
new
crossreact
pathogen
third
traffick
antigenexperienc
cell
may
alter
age
exampl
follow
respiratori
viru
infect
small
pool
virusspecif
cell
maintain
lung
airway
mice
age
recruit
memori
cell
airway
decreas
may
result
diminish
number
effector
memori
cell
alter
memori
tcell
traffick
profil
decreas
recruit
protect
cell
lung
airway
could
profound
effect
initi
control
viru
replic
elderli
whether
cell
lose
function
time
controversi
sever
studi
indic
age
cell
retain
effector
function
follow
primari
respons
mainten
memori
cell
acut
lymphocyt
choriomening
viru
sendai
viru
infect
young
age
mice
equival
interestingli
tcell
memori
gener
respiratori
virus
young
mice
may
actual
improv
time
equal
number
sendai
virusspecif
cell
isol
mice
infect
month
month
earlier
adopt
transfer
naiv
congen
host
infect
sendai
viru
virusspecif
cell
gener
month
earlier
made
greater
proport
secondari
respons
lung
lung
airway
prior
transfer
popul
memori
cell
similar
express
pattern
traffick
molecul
suggest
observ
differ
two
memori
tcell
popul
result
differenti
traffick
convers
tcell
respons
gener
age
mice
may
defect
provid
poor
protect
secondari
challeng
equal
number
sendai
virusspecif
memori
cell
gener
either
young
old
mice
adopt
transfer
naiv
mice
subsequ
challeng
sendai
viru
memori
cell
establish
age
mice
prolifer
poorli
compar
memori
cell
gener
young
mice
although
possibl
poor
tcell
help
rule
suggest
similar
cell
naiv
cell
accumul
defect
time
neutral
virusspecif
antibodi
contribut
viru
clearanc
primari
infect
import
protect
reinfect
upon
infect
pathogen
naiv
b
cell
recogn
cognat
antigen
presenc
tcell
help
activ
form
germin
center
hypersomat
mutat
class
switch
affin
matur
bcell
receptor
occur
stabl
memori
popul
b
cell
antibodysecret
plasma
cell
establish
protect
reinfect
depend
pathogen
memori
b
cell
neutral
antibodi
maintain
short
decad
whole
lifetim
host
much
thymic
output
decreas
time
age
deleteri
effect
multipl
stage
primari
bcell
develop
bone
marrow
anim
model
demonstr
signific
reduct
probcel
number
increas
age
bcell
receptor
light
chain
rearrang
also
impair
age
result
decreas
number
prob
cell
success
transit
preb
cell
matur
b
cell
exit
bone
marrow
traffic
secondari
lymphoid
tissu
traffick
matur
b
cell
bone
marrow
spleen
diminish
age
anim
possibl
method
compens
peripher
b
cell
turnov
slower
rate
longer
halflif
humor
respons
clearli
declin
age
particularli
evid
decreas
efficaci
immun
elderli
appear
bcell
memori
establish
young
individu
maintain
long
year
postimmun
retain
abil
mount
anamnest
respons
sever
decad
later
howev
compar
young
individu
bcell
respons
pathogen
age
individu
abbrevi
decreas
germin
center
format
antibodi
less
protect
owe
lower
titer
affin
also
agedepend
increas
level
low
affin
autoantibodi
sinc
tcell
help
necessari
germin
center
format
difficult
separ
agerel
defect
intrins
b
cell
cell
anoth
possibl
caus
decreas
germin
center
format
diminish
function
follicular
dendrit
cell
similar
agerel
chang
tcell
repertoir
previous
describ
bcell
repertoir
chang
age
small
number
age
adult
individu
older
year
old
respect
develop
benign
monoclon
gammopathi
defin
clonal
expans
memori
plasma
cell
produc
singl
immunoglobulin
also
skew
bcell
pool
mostli
compris
naiv
b
cell
young
individu
predomin
memoryphenotyp
bcell
pool
phenomenon
requir
investig
memori
phenotyp
b
cell
heterogen
previous
thought
also
agedepend
decreas
bcell
receptor
divers
may
limit
naiv
bcell
repertoir
capabl
respond
new
pathogen
nonpandem
influenza
viru
lead
caus
virusinduc
sever
respiratori
diseas
elderli
popul
approxim
influenzaassoci
death
occur
adult
age
year
even
high
rate
influenza
vaccin
influenza
infect
healthi
elderli
patient
highrisk
adult
result
greater
death
hospit
annual
usa
substanti
diseas
burden
caus
influenza
infect
elderli
emphas
need
better
understand
age
affect
influenzaspecif
adapt
immun
respons
cellmedi
humor
immun
respons
play
import
role
influenza
viru
clearanc
protect
reinfect
cell
requir
clearanc
influenza
viru
primari
infect
cell
alon
provid
partial
protect
influenza
infect
wherea
cell
abl
resolv
infect
influenzaspecif
antibodi
protect
reinfect
addit
evid
humor
respons
aid
viru
clearanc
primari
influenza
infect
variou
studi
report
agedepend
chang
frequenc
cell
other
show
clear
decreas
differ
may
account
vari
histori
natur
influenza
infect
vaccin
subject
analyz
method
detect
one
human
studi
examin
frequenc
effector
memori
central
memori
influenzaspecif
cell
young
age
subject
follow
influenza
vaccin
total
month
postimmun
age
subject
significantli
lower
frequenc
influenzaspecif
peripher
blood
cell
wherea
young
subject
equival
frequenc
total
effector
central
memori
cell
age
subject
exhibit
increas
ratio
central
memori
effector
memori
cell
shift
present
ex
vivo
influenzaspecif
cell
chang
balanc
effector
central
memori
cell
could
alter
abil
memori
cell
traffic
lung
upon
reinfect
influenza
could
lessen
qualiti
protect
studi
age
mice
human
demonstr
ageassoci
declin
tcell
respons
influenza
outlin
previous
repertoir
divers
size
tcell
respons
alter
age
sever
way
increas
ratio
memori
naiv
cell
age
decreas
number
naiv
precursor
respond
given
epitop
clonal
expans
memori
cell
domin
tcell
pool
first
age
mice
magnitud
tcell
respons
immunodomin
influenza
epitop
np
smaller
owe
contract
number
naiv
precursor
capabl
respond
addit
smaller
npspecif
respons
tcell
receptor
profil
skew
limit
divers
compar
npspecif
respons
young
mice
importantli
appear
tcell
specif
compens
decreas
npspecif
tcell
respons
sinc
size
npspecif
respons
age
mice
directli
correl
viru
clearanc
heterosubtyp
infect
highlight
import
examin
tcell
respons
individu
epitop
rather
simpli
examin
tcell
respons
whole
may
appear
differ
young
individu
second
clonal
expans
influenzaspecif
memori
cell
develop
time
mice
although
function
phenotyp
profil
influenzaspecif
tcell
clonal
expans
thoroughli
studi
clonal
expans
sendai
viru
mice
similar
memori
phenotyp
normal
tcell
respons
produc
upon
peptid
stimul
thu
apart
function
defect
acquir
age
alter
repertoir
tcell
pool
drastic
effect
overal
tcell
respons
influenza
clonal
expans
influenzaspecif
cell
difficult
examin
human
owe
wide
heterogen
respons
may
import
role
decreas
qualiti
influenzaspecif
tcell
respons
elderli
one
human
studi
examin
tcell
repertoir
elderli
subject
fail
produc
protect
antibodi
influenza
vaccin
major
subject
clonal
expans
cell
domin
major
famili
produc
autoantigen
propos
overproduct
could
caus
imbal
cytokin
result
defici
humor
respons
mous
model
also
use
evalu
effect
age
tcell
effector
activ
age
mice
decreas
cytolyt
activ
npspecif
cell
strongli
correl
decreas
number
npspecif
cell
determin
tetram
product
furthermor
tcell
respons
correspond
peak
cytolyt
activ
delay
viru
replic
prolong
similarli
age
balbc
mice
exhibit
decreas
tcell
cytolyt
activ
peak
activ
delay
sever
day
expect
decreas
cytotox
correl
significantli
delay
viru
clearanc
result
suggest
diminish
influenzaspecif
tcell
respons
decreas
tcell
effector
function
caus
reduc
cytolyt
activ
prolong
viru
replic
age
mice
human
peripher
blood
cell
age
adult
decreas
influenzaspecif
cytolyt
activ
compar
young
adult
sever
human
studi
examin
cellular
respons
prior
immun
trival
influenza
vaccin
rel
young
subject
cell
age
subject
prolifer
less
ex
vivo
produc
less
one
studi
compar
frequenc
influenza
cell
monitor
level
tetram
wherea
differ
tetram
frequenc
young
old
subject
old
subject
significantli
fewer
cell
produc
upon
restimul
suggest
cell
function
impair
thu
contrast
studi
perform
mice
human
studi
indic
decreas
effector
function
may
also
contribut
diminish
tcell
respons
age
individu
humor
immun
wane
age
illustr
much
reduct
vaccin
efficaci
individu
age
year
older
wherea
influenza
vaccin
efficaci
young
adult
efficaci
adult
age
older
year
influenza
vaccin
particularli
ineffect
prevent
sever
diseas
person
chronic
cardiopulmonari
condit
decreas
antibodi
respons
elicit
vaccin
probabl
combin
defici
bcell
respons
poor
help
cognat
cell
multipl
studi
report
differ
magnitud
antibodi
respons
elicit
vaccin
young
versu
age
subject
contrast
sever
studi
report
healthi
highrisk
elderli
adult
fail
achiev
hemagglutin
inhibit
hi
antibodi
titer
greater
follow
vaccin
consid
cutoff
protect
wherea
young
adult
vaccin
exhibit
hi
titer
greater
furthermor
percentag
elderli
subject
achiev
fourfold
increas
antibodi
titer
rel
preimmun
titer
appreci
lower
interestingli
elderli
compar
young
adult
exhibit
fourfold
higher
increas
antibodi
titer
booster
immun
vaccin
compon
use
previou
year
anoth
group
similarli
report
fraction
elderli
subject
mount
fourfold
higher
increas
antibodi
titer
compar
young
subject
reimmun
importantli
one
studi
found
major
immun
elderli
individu
infect
influenza
hi
titer
greater
titer
greater
indic
titer
perhap
strong
indic
protect
qualiti
antibodi
respons
may
also
import
altern
level
protect
contribut
neutral
antibodi
may
similar
elderli
young
adult
howev
second
line
defens
elicit
memori
cell
may
defici
age
individu
respiratori
syncyti
viru
lead
caus
sever
lower
respiratori
viru
infect
infant
children
age
year
recent
rsv
recogn
signific
diseas
burden
elderli
rsv
second
influenza
caus
virusinduc
sever
respiratori
diseas
adult
age
year
estim
rsvassoci
mortal
occur
adult
age
year
annual
rsv
infect
approxim
healthi
elderli
adult
approxim
mortal
rate
result
death
per
year
usa
accompani
hospit
cost
much
us
billion
year
signific
diseas
burden
elderli
popul
highlight
need
effect
rsv
vaccin
spite
signific
pathogenesi
elderli
littl
known
effect
age
immun
respons
rsv
clear
human
mice
cellmedi
immun
humor
immun
import
resolv
rsv
infect
protect
reinfect
children
defect
cellmedi
immun
exhibit
prolong
viru
shed
accompani
increas
diseas
sever
mortal
cell
import
resolv
acut
rsv
infect
mice
tcell
deplet
prior
primari
rsv
infect
caus
prolong
viru
replic
lung
human
titer
rsvspecif
antibodi
correl
decreas
suscept
reinfect
rsv
substanti
balbc
mous
model
wherebi
antibodi
import
viru
clearanc
primari
infect
protect
reinfect
howev
unlik
mice
human
rsvspecif
antibodi
may
provid
steril
immun
sinc
reinfect
commonli
occur
throughout
life
thu
understand
effect
age
adapt
immun
respons
critic
understand
increas
diseas
caus
rsv
infect
elderli
sever
studi
directli
examin
immun
respons
rsv
infect
human
age
anim
model
similar
influenza
infect
age
anim
model
age
mice
cotton
rat
demonstr
decreas
cellmedi
immun
respons
accompani
increas
morbid
rsv
infect
age
anim
exhibit
delay
viru
clearanc
decreas
delay
inflammatori
cytokin
level
increas
cytokin
support
degen
tcell
respons
rsvinfect
senescenceacceler
mous
strain
mice
age
balbc
mice
exhibit
decreas
ex
vivo
cytolyt
activ
cell
nk
cell
addit
age
balbc
mice
decreas
number
pulmonari
cell
compar
young
mice
owe
either
increas
viru
burden
immunopatholog
diseas
sever
anim
increas
age
mice
exhibit
increas
weight
loss
increas
inflamm
lung
follow
acut
rsv
infect
human
studi
examin
effect
age
rsvspecif
cell
report
frequenc
rsvspecif
tetram
cell
slowli
decreas
age
subject
chronic
obstruct
pulmonari
diseas
median
age
year
sever
healthi
subject
older
year
detect
frequenc
rsv
tetram
cell
agreement
tetram
frequenc
anoth
studi
demonstr
elderli
adult
significantli
fewer
rsvspecif
peripher
blood
cell
compar
young
adult
determin
enzymelink
immunosorb
spot
elispot
assay
contrast
anoth
group
observ
signific
decreas
frequenc
rsvspecif
cell
young
elderli
adult
see
agedepend
decreas
ratio
cell
suggest
balanc
antiand
proinflammatori
cell
may
shift
age
howev
human
studi
need
determin
whether
magnitud
cytokin
profil
rsvspecif
tcell
respons
chang
age
collect
data
suggest
alterationattrit
tcell
respons
elderli
age
tcell
respons
inde
diminish
clear
whether
rsvspecif
tcell
respons
decreas
owe
contract
naiv
repertoir
competit
memori
tcell
clonal
expans
whether
cell
intrins
defect
whether
tcell
respons
effici
prime
antigenpres
cell
whether
combin
possibl
furthermor
sinc
human
studi
limit
analyz
cell
circul
peripher
blood
data
may
reflect
differ
number
qualiti
rsvspecif
lungresid
cell
human
anim
virusspecif
memori
cell
preferenti
maintain
lung
long
resolut
infect
sinc
cell
pois
respond
immedi
respiratori
viru
infect
import
determin
ageassoci
chang
occur
cell
popul
respiratori
syncyti
viru
neutral
antibodi
reduc
suscept
reinfect
rsv
young
age
adult
human
mucos
rsvspecif
iga
antibodi
correl
close
protect
serumneutr
antibodi
observ
valid
balbc
mous
model
antibodi
protect
rsv
infect
reinfect
rsv
common
despit
presenc
rsvspecif
antibodi
memori
cell
suggest
natur
acquir
immun
rsv
either
rapidli
wane
never
fulli
establish
consist
observ
fairli
rapid
decay
serum
antibodi
titer
natur
rsv
infect
follow
rsv
infect
neutral
antibodi
titer
decreas
fourfold
year
major
subject
initi
decreas
titer
decay
rate
probabl
level
sinc
subject
reinfect
rsv
maintain
stabl
antibodi
level
low
decay
rate
appear
decay
rate
differ
age
although
yet
care
assess
unknown
serum
decay
rate
appli
mucos
antibodi
titer
unclear
whether
humor
respons
intact
elderli
mice
infect
rsv
decreas
mucos
rsvspecif
iga
antibodi
correl
decreas
tcell
respons
young
age
mice
differ
mucos
antibodi
human
multipl
group
observ
similar
baselin
rsv
antibodi
titer
young
age
subject
one
prospect
studi
actual
found
elderli
cohort
vigor
antibodi
respons
young
adult
follow
natur
rsv
infect
mean
increas
neutral
antibodi
age
adult
approxim
eightfold
compar
approxim
fourfold
increas
young
adult
studi
examin
individu
antibodi
isotyp
mucos
antibodi
titer
might
reveal
ageassoci
differ
recent
studi
itali
found
nearli
elderli
year
age
young
year
age
subject
rsvspecif
antibodi
age
individu
neutral
antibodi
compar
young
individu
compar
young
cohort
seroposit
subject
age
cohort
also
significantli
lower
mean
neutral
titer
perhap
reflect
decay
rsvspecif
antibodi
investig
requir
close
examin
divers
affin
rsvspecif
neutral
antibodi
elderli
may
vitro
rsv
neutral
assay
sensit
enough
detect
agerel
differ
affin
andor
divers
antibodi
specif
may
decreas
enough
elderli
diminish
protect
reinfect
would
also
inform
assess
rsvspecif
tcell
bcell
respons
parallel
antibodi
titer
order
link
ageassoci
decreas
humor
immun
upstream
event
current
unknown
whether
agerel
decreas
bcell
repertoir
poor
germin
center
format
limit
humor
respons
rsv
addit
defect
age
b
cell
may
accru
tcell
help
bcell
respons
may
poor
elderli
age
mous
model
use
analyz
effect
age
magnitud
qualiti
tcell
bcell
respons
affect
antibodi
product
human
metapneumoviru
identifi
netherland
sinc
identifi
major
caus
respiratori
tract
diseas
infant
young
children
worldwid
hmpv
caus
approxim
sever
respiratori
infect
infant
clinic
symptom
similar
rsv
major
children
infect
age
year
almost
adult
seroposit
hmpv
reinfect
hmpv
suggest
similar
rsv
protect
immun
establish
follow
natur
infect
appreci
hmpv
infect
peopl
age
includ
elderli
hmpv
infect
rate
high
young
adult
probabl
owe
increas
exposur
children
diseas
sever
greatest
highrisk
elderli
adult
underli
chronic
heart
lung
condit
emphas
combin
contribut
cardiopulmonari
disord
frailti
immun
senesc
increas
sever
respiratori
viru
infect
elderli
popul
age
balbc
mice
exhibit
delay
weight
recoveri
increas
clinic
ill
mortal
increas
airway
obstruct
compar
young
mice
follow
acut
hmpv
infect
peak
viru
titer
lung
higher
age
mice
viru
clearanc
similar
young
mice
suggest
earli
innat
immun
respons
hmpv
declin
age
similar
influenza
rsv
infect
cellmedi
immun
respons
import
control
hmpv
replic
age
balbc
mice
infect
hmpv
similar
number
cell
lung
airway
significantli
cell
accompani
increas
number
cell
day
postinfect
age
mice
exhibit
decreas
level
increas
level
day
postinfect
detect
elisa
bronchoalveolar
lavag
fluid
clear
account
overal
decreas
level
data
suggest
shift
thelper
cell
th
tcell
respons
may
contribut
exacerb
diseas
age
mice
human
metapneumovirusspecif
antibodi
protect
reinfect
balbc
mice
infect
age
mice
hmpv
induc
significantli
lower
level
igg
isotyp
isotyp
young
mice
day
postinfect
level
significantli
lower
day
postinfect
suggest
agerel
shift
tcell
respons
neutral
antibodi
titer
approxim
threefold
lower
age
mice
compar
young
mice
chang
type
tcell
respons
may
caus
decreas
antibodi
titer
also
possibl
ageassoci
defici
tcell
help
contribut
poor
humor
respons
sinc
hmpv
newli
describ
respiratori
pathogen
human
studi
compar
humor
cellmedi
immun
respons
elderli
young
adult
diseas
burden
respiratori
viru
infect
elderli
highrisk
adult
virus
influenza
viru
rsv
hmpv
receiv
littl
attent
respiratori
virus
contribut
diseas
burden
elderli
highrisk
adult
includ
hpiv
rhinoviru
coronaviru
diseas
burden
virus
probabl
overshadow
predomin
influenza
rsv
infect
winter
month
overlap
clinic
symptom
virus
owe
insensit
diagnost
test
rel
contribut
hpiv
rhinoviru
coronaviru
sever
respiratori
diseas
elderli
probabl
increas
rapid
realtim
pcr
test
becom
common
addit
studi
limit
winter
month
peak
rsv
influenza
infect
may
accur
assess
sever
respiratori
diseas
caus
virus
rhinoviru
hpiv
occur
throughout
year
variou
period
sever
studi
test
patient
admit
hospit
acut
respiratori
condit
wide
varieti
common
respiratori
virus
studi
bias
toward
highrisk
patient
one
studi
examin
elderli
adult
hospit
sever
lower
respiratori
tract
infect
found
hpiv
associ
infect
anoth
studi
found
hpiv
infect
account
similar
frequenc
respiratori
viru
infect
rsv
hospit
patient
older
year
age
chronic
pulmonari
disord
hpiv
compar
rsv
prospect
studi
nurs
home
found
hpiv
infect
account
respiratori
ill
differ
infect
rate
report
studi
may
attribut
method
identif
period
hpiv
infect
environment
risk
factor
togeth
studi
demonstr
hpiv
significantli
contribut
diseas
burden
elderli
highrisk
adult
addit
prospect
investig
identifi
natur
rate
hpiv
infect
mortal
healthi
young
elderli
adult
requir
accur
assess
rel
diseas
burden
elderli
popul
current
clear
agerel
chang
immun
system
contribut
diseas
sever
hpiv
infect
rhinoviru
coronaviru
infect
healthi
adult
gener
mild
major
infect
asymptomat
requir
hospit
howev
accumul
evid
virus
significantli
contribut
diseas
burden
age
adult
especi
chronic
cardiopulmonari
condit
prospect
studi
england
examin
communitydwel
adult
age
year
report
rhinovirus
coronavirus
identifi
report
respiratori
infect
respect
compar
influenza
rsv
anoth
studi
usa
identifi
rhinoviru
coronaviru
infect
elderli
patient
admit
hospit
respiratori
condit
underli
cardiopulmonari
diseas
cancer
also
report
sever
rhinoviru
outbreak
nurs
home
rhinoviru
infect
commonli
identifi
dual
respiratori
viru
infect
could
contribut
increas
diseas
sever
hpiv
agerel
chang
adapt
immun
respons
rhinoviru
coronaviru
well
studi
conclus
influenza
rsv
hmpv
infect
probabl
account
major
sever
acut
respiratori
viru
infect
import
recogn
viru
infect
signific
caus
morbid
elderli
highrisk
adult
age
affect
cellmedi
humor
respons
tand
bcell
develop
divers
size
peripher
naiv
tand
bcell
pool
primari
adapt
immun
respons
respiratori
virus
mainten
immunolog
memori
abil
mount
secondari
respons
owe
either
increas
viru
replic
inappropri
immun
respons
senesc
immun
system
may
major
contributor
increas
diseas
sever
respiratori
viru
infect
elderli
howev
highrisk
factor
chronic
cardiopulmonari
condit
undoubtedli
contribut
increas
morbid
mortal
highrisk
function
disabl
adult
like
requir
hospit
sever
respiratori
viru
infect
higher
mortal
rate
understand
ageassoci
defect
adapt
immun
respons
respiratori
viru
infect
come
influenza
rsv
studi
gener
cytolyt
tcell
respons
decreas
magnitud
delay
result
prolong
viru
replic
diminut
virusspecif
tcell
respons
probabl
occur
part
decreas
number
naiv
cell
abl
respond
viral
antigen
competit
new
tcell
respons
clonal
expans
memori
cell
poor
prolif
capac
effect
ageassoci
defect
tcell
help
tcell
respons
receiv
littl
attent
tcell
help
import
maintain
memori
cell
gener
robust
secondari
respons
defect
cell
primarili
studi
age
anim
use
model
antigen
tcell
receptor
transgen
cell
futur
studi
need
address
agerel
defect
tcell
respons
respiratori
virus
effect
poor
tcell
help
cell
b
cell
declin
humor
respons
respiratori
viru
infect
best
exemplifi
decreas
influenza
vaccin
efficaci
remain
disagr
field
regard
whether
antibodi
respons
diminish
age
agerel
defect
antibodymedi
protect
probabl
result
reduct
quantiti
neutral
antibodi
qualiti
eg
decreas
affin
divers
antibodi
sinc
bcell
respons
requir
tcell
help
import
establish
whether
defect
tcell
respons
contribut
attenu
antibodi
protect
effect
age
tcell
help
humor
respons
respiratori
viru
infect
directli
explor
addit
futur
studi
need
establish
whether
contract
bcell
repertoir
decreas
antibodi
qualiti
link
poor
humor
respons
elderli
gain
better
understand
basic
cellular
chang
occur
senesc
immun
system
abl
design
vaccin
immunotherapi
circumv
defect
boost
immun
respons
sinc
vaccin
effect
method
prevent
ill
prioriti
given
design
vaccin
protect
elderli
highrisk
adult
vaccin
respiratori
virus
probabl
need
abl
induc
humor
cellmedi
immun
provid
multipl
line
defens
infect
influenza
viru
respiratori
syncyti
viru
rsv
lead
caus
virusinduc
sever
respiratori
diseas
elderli
highrisk
adult
human
metapneumoviru
human
parainfluenza
viru
rhinoviru
coronaviru
also
contribut
respiratori
diseas
burden
elderli
highrisk
adult
immun
senesc
addit
increas
frailti
highrisk
condit
chronic
cardiopulmonari
disord
lead
increas
hospit
mortal
rate
elderli
gener
cellmedi
respons
decreas
age
owe
chang
peripher
tcell
pool
accumul
tcell
intrins
defect
age
individu
exhibit
decreas
virusspecif
tcell
respons
delay
peak
cytolyt
activ
concomit
prolong
viru
replic
humor
immun
respons
decreas
age
illustr
approxim
reduct
influenza
vaccin
efficaci
elderli
individu
gener
virusspecif
antibodi
titer
lower
elderli
adult
compar
young
adult
influenza
vaccin
age
individu
antibodi
titer
would
normal
protect
young
adult
exhibit
higher
risk
infect
compar
young
vaccin
individu
suggest
antibodi
elderli
decreas
qualiti
defect
cellmedi
humor
immun
contribut
increas
infect
rate
diseas
sever
elderli
adult
clear
whether
decreas
humor
immun
due
b
cellintrins
defect
defici
tcell
help
futur
studi
need
directli
examin
agerel
chang
cell
alter
humor
respons
respiratori
virus
design
vaccin
induc
strong
humor
cellmedi
immun
elderli
prioriti
use
adjuv
cytokin
vaccin
may
particularli
use
elicit
protect
immun
paper
special
note
highlight
interest
